Trials / Completed
CompletedNCT01471093
Safety Study of OPC-12759 Ophthalmic Solution
Safety Study of OPC-12759 Ophthalmic Solution in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety of OPC-12759 ophthalmic solution in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPC-12759 Ophthalmic solution | 2％ OPC-12759 Ophthalmic solution |
| DRUG | OPC-12759 Ophthalmic suspension | 2％ OPC-12759 Ophthalmic suspension |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2011-12-01
- Completion
- 2012-02-01
- First posted
- 2011-11-11
- Last updated
- 2021-06-29
- Results posted
- 2021-06-29
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01471093. Inclusion in this directory is not an endorsement.